Navis Wealth Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $531K | Hold |
4,199
| – | – | 0.45% | 50 |
|
|
2025
Q1 | $537K | Buy |
4,199
+4
| +0.1% | +$512 | 0.53% | 43 |
|
|
2024
Q4 | $555K | Buy |
4,195
+2
| +0% | +$264 | 0.61% | 40 |
|
|
2024
Q3 | $611K | Buy |
4,193
+6
| +0.1% | +$874 | 0.66% | 38 |
|
|
2024
Q2 | $575K | Sell |
4,187
-181
| -4% | -$24.8K | 0.66% | 37 |
|
|
2024
Q1 | $599K | Buy |
4,368
+4
| +0.1% | +$549 | 0.72% | 33 |
|
|
2023
Q4 | $593K | Buy |
4,364
+10
| +0.2% | +$1.36K | 0.77% | 32 |
|
|
2023
Q3 | $532K | Hold |
4,354
| – | – | 0.77% | 31 |
|
|
2023
Q2 | $553K | Hold |
4,354
| – | – | 0.51% | 31 |
|
|
2023
Q1 | $562K | Buy |
4,354
+2
| +0% | +$258 | 0.62% | 29 |
|
|
2022
Q4 | $571K | Buy |
+4,352
| New | +$571K | 0.81% | 27 |
|